Related Experiment Video
Updated: Aug 14, 2026
08:30
Immunophenotyping of Orthotopic Homograft (Syngeneic) of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
Paraproteinemia and neoplasia
La Ricerca in Clinica E in Laboratorio
|April 1, 1985
Summary
Paraproteinemias, conditions involving abnormal proteins, are frequently linked to a second cancer. This association is higher than expected, particularly with IgM paraproteinemias, suggesting a need for cautious prognosis.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Paraproteinemias, including myelomatous and non-myelomatous types, are associated with a higher-than-expected incidence of second malignant neoplasms.
- This association occurs in 10-22% of cases, significantly exceeding rates seen with other cancer combinations.
Purpose of the Study:
- To investigate the frequency and characteristics of the association between paraproteinemia and secondary malignancies.
- To analyze the relationship between specific immunoglobulin (Ig) classes and associated neoplasias.
Main Methods:
- Retrospective analysis of 311 cases of paraproteinemia.
- Comparison of observed neoplasia frequencies with statistically expected rates.
- Evaluation of Ig class distribution in relation to associated cancers.
Main Results:
- The paraproteinemia-neoplasia association was observed in 10% of the studied cases.
- Epithelial neoplasias were more frequently associated with paraproteinemias than lymphoreticular neoplasias in this series.
- IgM paraproteinemias showed a higher prevalence (22.5%) and a strong association (approx. 50%) with lymphoreticular malignancies.
Conclusions:
- The frequent occurrence of a second neoplasia, especially with IgM paraproteinemias, indicates a significant prognostic risk.
- Findings suggest that non-myelomatous paraproteinemias may not always be benign and warrant careful evaluation for secondary malignancies.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...